Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 3
2007 5
2008 3
2009 6
2010 2
2011 4
2012 3
2014 3
2015 5
2016 4
2017 2
2019 5
2020 9
2021 9
2022 11
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Metastatic Prostate Cancer: Treatment Options.
Achard V, Putora PM, Omlin A, Zilli T, Fischer S. Achard V, et al. Oncology. 2022;100(1):48-59. doi: 10.1159/000519861. Epub 2021 Nov 15. Oncology. 2022. PMID: 34781285 Review.
Letter from Switzerland.
Achard V, Tsoutsou P, Zilli T. Achard V, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):600-601. doi: 10.1016/j.ijrobp.2020.03.008. Epub 2020 Mar 19. Int J Radiat Oncol Biol Phys. 2020. PMID: 32199942 Free PMC article. No abstract available.
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus.
Zilli T, Achard V, Dal Pra A, Schmidt-Hegemann N, Jereczek-Fossa BA, Lancia A, Ingrosso G, Alongi F, Aluwini S, Arcangeli S, Blanchard P, Conde Moreno A, Couñago F, Créhange G, Dirix P, Gomez Iturriaga A, Guckenberger M, Pasquier D, Sargos P, Scorsetti M, Supiot S, Tree AC, Zapatero A, Le Guevelou J, Ost P, Belka C. Zilli T, et al. Among authors: achard v. Radiother Oncol. 2022 Nov;176:199-207. doi: 10.1016/j.radonc.2022.10.005. Epub 2022 Oct 10. Radiother Oncol. 2022. PMID: 36228761 Free article.
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte F, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P. Zilli T, et al. Among authors: achard v. Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29. Eur Urol Focus. 2021. PMID: 33386290 Free article. Clinical Trial.
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Arcos MBL, López-Campos F, Valcarcel ML, Rubio MG, de Manzanos IVF, Duque-Santana V, Aparicio MG, Martin JZ, Kishan AU, Achard V, Siva S, Couñago F. Arcos MBL, et al. Among authors: achard v. Clin Genitourin Cancer. 2023 Jun;21(3):e93-e103. doi: 10.1016/j.clgc.2022.10.015. Epub 2022 Nov 11. Clin Genitourin Cancer. 2023. PMID: 36456467 Review.
Oligometastatic prostate cancer: The game is afoot.
Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez-Iturriaga A, Ingrosso G, Liefhooghe N, Miralbell R, Siva S, Van der Eecken K, Ost P. Lancia A, et al. Among authors: achard v. Cancer Treat Rev. 2019 Feb;73:84-90. doi: 10.1016/j.ctrv.2019.01.005. Epub 2019 Jan 17. Cancer Treat Rev. 2019. PMID: 30684842 Review.
77 results